News: Microelectronics
3 August 2020
Transphorm trading on OTC market under symbol TGAN
Transphorm Inc of Goleta, near Santa Barbara, CA, USA — which designs and manufactures JEDEC- and AEC-Q101-qualified 650V gallium nitride (GaN) field-effect transistors (FETs) — has received approval from FINRA (Financial Industry Regulatory Authority Inc) for its common stock to be listed and quoted on the Over-the-Counter (OTC) market. Transphorm is trade on the OTCQB under the symbol ‘TGAN’ as of market opeing on 3 August.
Transphorm’s public listing marks “an important milestone in the company’s evolution,” say co-founders Umesh Mishra Ph.D. (chief technology officer) and Primit Parikh Ph.D. (chief operating officer). “The listing of our common stock provides both existing and prospective investors with direct access to invest in Transphorm and participate in our future anticipated growth as we continue to scale Transphorm’s high-voltage GaN products for power conversion applications across our growing base of customers,” they add.
Transphorm’s product portfolio consists of both 650V and 900V GaN FETs for high-voltage power conversion applications ranging from 30W to over 10kW, including the industry’s first JEDEC (commercial/industrial)- and AEC-Q101 (automotive)-qualified 650V devices and the only 900V GaN device on the market, it is claimed. With an IP portfolio that exceeds 1000 patents, the firm’s products offer the quality and reliability (Q+R) backed by field performance of less than 1 failure per billion hours of operation spanning 65W (adapters/fast chargers) products to 4kW (power supplies/UPS) products. The AEC-qualified devices are currently being evaluated by electric vehicle (EV) power conversion suppliers and design partners for design-in on future automotive applications. Transphorm is actively ramping volume production in support of the growing adoption of its GaN power FETs, targeting power adapter, computing, uninterruptible power supply (UPS), data-center and communications infrastructure applications.
Transphorm raises $21m and completes reverse merger
